Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long‐Term Outcomes in a Prospective, Single‐Arm Trial

We observed favorable OS and EFS after AHSCT for patients with SSc, using CY200/ATG, unmanipulated PBSCs, and MMF posttransplant maintenance, which was comparable to trials with CD34+ graft selection. We identified a possible risk factor, pretransplant low eGFR, for adverse outcomes after AHSCT.

Authors

Institutions

Publication Details

Journal
Arthritis & Rheumatology
Published
2024-12-03
DOI
https://doi.org/10.1002/art.43072
Citations
4
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
1.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long‐Term Outcomes in a Prospective, Single‐Arm Trial

Vaishali Sanchorawala, Attaphol Pawarode, George E. Georges, Ted Alan Gooley et al.
4 citations
Arthritis & Rheumatology
Systemic Sclerosis and Related Diseases
1.70
article

Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long‐Term Outcomes in a Prospective, Single‐Arm Trial

Vaishali Sanchorawala, Attaphol Pawarode, George E. Georges, Ted Alan Gooley, Maureen D. Mayes, Suzanne Kafaja, Keith M. Sullivan, Chitra Hosing, Mark H. Wener, Daniel E. Furst, Matthew Mei, Richard A. Nash, Jason Kolfenbach, Dinesh Khanna, Robert W. Simms, Leona Holmberg, Suiyuan Huang
article en
4 citations

Abstract

We observed favorable OS and EFS after AHSCT for patients with SSc, using CY200/ATG, unmanipulated PBSCs, and MMF posttransplant maintenance, which was comparable to trials with CD34+ graft selection. We identified a possible risk factor, pretransplant low eGFR, for adverse outcomes after AHSCT.

Arthritis & RheumatologyVol. 77(5)
Dartmouth College (US), Boston University (US), Northwestern University (US), Boston Medical Center (US), City Of Hope National Medical Center (US), The University of Texas MD Anderson Cancer Center (US), University of California, Los Angeles (US), Duke University (US), University of Washington (US), University of Michigan (US), Fred Hutch Cancer Center (US), Colorado Blood Cancer Institute (US), Scleroderma Foundation (US), University of Houston (US), University of Colorado Anschutz Medical Campus (US), Seattle University (US)
University of Washington, Comprehensive Cancer Center, City of Hope, McGovern Medical School, University of California, Los Angeles
Good health and well-being
Openalex Percentile: Top 15%
Systemic Sclerosis and Related Diseases
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.